🇺🇸 FDA
Patent

US 7439027

Method for modulating process mediated by farnesoid activated receptors

granted A61KA61K31/045A61K31/202

Quick answer

US patent 7439027 (Method for modulating process mediated by farnesoid activated receptors) held by Ligand Pharmaceuticals Incorporated expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/045, A61K31/202, A61K31/22, A61K31/336